{"id":"W2749747068","doi":"10.1016/s1470-2045(17)30517-x","title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1113,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Foothills Medical Centre; University of Calgary; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"Celldex Therapeutics","keywords":"Temozolomide; Medicine; Internal medicine; Clinical endpoint; Oncology; Progression-free survival; Phases of clinical research; Clinical trial; Chemotherapy; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001363688,0.001907974,0.002451013,0.0003810292,0.0003648341,0.00105627,0.000880116,0.001578662,0.005076693],"category_scores_gemma":[0.001313519,0.0006673981,0.001982558,0.000414418,0.001146988,0.001410437,0.0004148679,0.003505762,0.0009995507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009673343,"about_ca_system_score_gemma":0.001074302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001616977,"about_ca_topic_score_gemma":0.003768841,"domain_scores_codex":[0.9994853,0.000265686,0.00002397419,0.00009241874,0.00003180156,0.000100856],"domain_scores_gemma":[0.9995232,0.0001200478,0.0001085539,0.00004237868,0.00003118562,0.0001746459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9780198,0.002385694,0.0003420846,0.0005581848,0.001144928,0.00003449463,0.00006025329,0.0003747041,0.001779356,0.0001667977,0.001193869,0.01393978],"study_design_scores_gemma":[0.9692444,0.0281151,0.0009651184,0.00003027696,0.0003424995,0.00002897687,0.00002319058,0.000250502,0.0002093895,0.0002126388,0.0005641372,0.00001376391],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843622,0.006408061,0.0008136383,0.0009604316,0.0008516316,0.002494646,0.001012895,0.0001824761,0.00291418],"genre_scores_gemma":[0.9845253,0.003833538,0.001443393,0.00118313,0.0003779765,0.002827035,0.001112664,0.00003956804,0.004657405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005076693,"threshold_uncertainty_score":0.01698327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05302134748243224,"score_gpt":0.3716507209685209,"score_spread":0.3186293734860886,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}